Inventor · disambiguated record
Achim H. Krauss
Also filed as: KRAUSS ACHIM H · KRAUSS ACHIM H-P · KRAUSS ACHIM HANS-PETER
25 granted patents·5 pending applications·282 citations·filing 1993–2025
95Inventor score
Files withALLERGAN INC18ALLERGAN SALES INC3AXEROVISION INC3CS PHARMACEUTICALS LTD3BENEDINI FRANCESCA1
Top patents by PatentIndex Score
30 records- 0191US7070768B2Method for imparting artificial tan to human skinALLERGAN INC·Filed 2003·Granted Jul 4, 2006·40 cites·26 claims
- 0289US6395787B1Ocular hypotensive lipidsALLERGAN SALES INC·Filed 2000·Granted May 28, 2002·51 cites·34 claims
- 0388US6956057B2EP4 agonists as agents for lowering intraocular pressureALLERGAN INC·Filed 2003·Granted Oct 18, 2005·16 cites·13 claims
- 0485US5652236AMethod for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitorsALLERGAN INC·Filed 1996·Granted Jul 29, 1997·65 cites·5 claims
- 0583US8101658B2Nitric oxide donating prostamidesBENEDINI FRANCESCA·Filed 2009·Granted Jan 24, 2012·7 cites·19 claims
- 0682US7045634B2Prostamide receptor antagonistsALLERGAN INC·Filed 2004·Granted May 16, 2006·12 cites·1 claims
- 0781US7217725B2Prostaglandin D2 antagonistALLERGAN INC·Filed 2004·Granted May 15, 2007·11 cites·3 claims
- 0878US6713268B2Methods of identifying ocular hypotensive compounds having reduced hyperpigmentationALLERGAN INC·Filed 2001·Granted Mar 30, 2004·23 cites·6 claims
- 0973US7718656B2Prostaglandin derivativesNICOX SA·Filed 2006·Granted May 18, 2010·2 cites·17 claims
- 1072US12350277B2Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2023·Granted Jul 8, 2025·0 cites·24 claims
- 1172US7019149B2Thromboxane ligands without blood clotting side effectsALLERGAN INC·Filed 2004·Granted Mar 28, 2006·3 cites·6 claims
- 1270US10751334B2Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditionsAXEROVISION INC·Filed 2019·Granted Aug 25, 2020·0 cites·24 claims
- 1370US7273883B2Prostaglandin EP4 antagonistALLERGAN INC·Filed 2004·Granted Sep 25, 2007·4 cites·4 claims
- 1464US5516791A7-[carboxyakyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1]octane and derivatives thereofALLERGAN INC·Filed 1995·Granted May 14, 1996·8 cites·3 claims
- 1564US2025295672A1Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2025·Application pending·0 cites
- 1662US5741812AThromboxane ligands without blood clotting side effectsALLERGAN INC·Filed 1997·Granted Apr 21, 1998·9 cites·4 claims
- 1760US2020405703A1Pharmaceutical compositions comprising an integrin alpha4 antagonist for use in treating ocular inflammatory conditionsAXEROVISION INC·Filed 2020·Application pending·0 cites
- 1859US10413535B2Pharmaceutical compositions comprising an integrin ALPHA4 antagonist for use in treating ocular inflammatory conditionsAXEROVISION INC·Filed 2016·Granted Sep 17, 2019·0 cites·15 claims
- 1959US5602143AMethod for reducing intraocular pressure in the mammalian eye by administration of guanylate cyclase inhibitorsALLERGAN INC·Filed 1994·Granted Feb 11, 1997·19 cites·5 claims
- 2054US7612082B2Prostaglandin EP4 antagonistsALLERGAN INC·Filed 2004·Granted Nov 3, 2009·0 cites·2 claims
- 2154US5416106A7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl]3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereofALLERGAN INC·Filed 1993·Granted May 16, 1995·8 cites·6 claims
- 2253US2005058614A1Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amidesALLERGAN INC·Filed 2003·Application pending·0 cites
- 2352US6818779B2Thromboxane ligands without blood clotting side effectsALLERGAN INC·Filed 2002·Granted Nov 16, 2004·0 cites·2 claims
- 2452US2006106078A1Prostamide receptor antagonistsALLERGAN INC·Filed 2006·Application pending·0 cites
- 2551US5650431AThromboxane ligands without blood clotting side effectsALLERGAN INC·Filed 1996·Granted Jul 22, 1997·4 cites·8 claims
- 2650US6462077B1Thromboxane ligands without blood clotting side effectsALLERGAN INC·Filed 2001·Granted Oct 8, 2002·0 cites·9 claims
- 2747US11759472B2Compositions and methods of use for treating aberrant inflammation in peri-ocular secretory glands or at the ocular surfaceCS PHARMACEUTICALS LTD·Filed 2018·Granted Sep 19, 2023·0 cites·12 claims
- 2845US2016214956A1Novel soluble guanylate cyclase activators and their useGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Application pending·0 cites
- 2932US6090845AThromboxane ligandsALLERGAN SALES INC·Filed 1999·Granted Jul 18, 2000·0 cites·11 claims
- 3032US6017953AThromboxane ligandsALLERGAN SALES INC·Filed 1997·Granted Jan 25, 2000·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →